Episode 1057
TWiV 1057: CMV-based HIV vaccine with Klaus Früh
October 29, 20231h 21m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Klaus Früh visits the Incubator to discuss his career and his work on cytomegalovirus-vectored vaccines which are unique in their ability to persistently maintain an immune shield of effector memory T cells, including highly unconventional MHC-II and MHC-E restricted CD8+ T cells.
Host: Vincent Racaniello, Rich Condit, and Brianne Barker
Guest: Klaus Früh
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Spike shirts at vaccinated.us (promo code Microbetv)
- Research assistant position in Rosenfeld Lab CBER/FDA (pdf)
- HCMV-based attenuated vaccine platform (Sci Rep)
- HLA-E-restricted, Gag-specific CD8+ T cells suppress HIV-1 infection (Sci Immunol)
- RhCMV/SIV vaccine shows long-term efficacy against SIV challenge (Sci Transl Med)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]